China Pharma rescinds Dec 12 securities purchase agreement; deal void ab initio

CHINA PHARMA HOLDINGS, INC.

On Dec 23, 2024, company and an unnamed investor agreed to rescind the Dec 12 securities purchase agreement.
The rescission renders the agreement void from the beginning, as disclosed in prior 8-K filed Dec 13, 2024.
No details on investor or financial impact provided; agreement termination may affect expected capital infusion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.